Dräger Posts Strong Financial Results for 2024, Increases Dividend

In 2024, Drägerwerk AG & Co. KGaA reported a significant rise in net profit, accompanied by a higher dividend payout. The company experienced robust order intake, reaching EUR 3,381 million, surpassing the previous year's level by approximately EUR 90 million. Net sales were slightly down at EUR 3,370.9 million, close to last year’s figure due to improved delivery capacity and demand for ventilators in China.

Earnings before interest and taxes (EBIT) grew 16.6% to EUR 194.0 million, partly due to one-off effects. The dividend has been increased to EUR 1.97 per common share and EUR 2.03 per preferred share. The gains were driven by strong performance in Europe, the Americas, and high demand for protective and medical devices.

For 2025, Dräger anticipates net sales to rise between 1.0% and 5.0%, aiming for an EBIT margin between 3.5% and 6.5%. The company also integrated a sustainability statement into its management report.